News About: Pharm. Industry
Pfizer Korea to appoint new presidentPfizer Korea announced on October 21 it has appointed Ahmet Goksun as a new president
Previously, the new Turkish president, had been responsible for various operations sinc...
|
Female sexual partners more satisfied with Cialis than men.
It was reported that Cialis gave a far higher satisfaction to women than men.
In the 11th conference of the international society of the erectile dysfunction held at Buenos Aires in Argentina, a study conducted by ...
Ketotop patch wins 2004 best brand award
Pacific Pharm said its Ketotop patch received the 2004 Best Brand Award on October 19, in a recent consumer-voting ceremony to have been jointly held by the Korean Customers' Forum and Korea Economic Daily.
The 200...
GSK to sell Ansan factory
GSK announced that it will sell its Ansan factory of Kyunggi Province, including land, animal wards, facility and machinery, etc., through public tender on October 28 following an explanatory session on October 22.
...
KPMA calls for more government's R&D investment
The Korean government needs to focus on the development of local pharmaceutical industry through substantial R&D investment programs to nurture it as one of the nation's core growth engines, according to data released...
Controversy sparks over CJ's trademark Simvasta
The ongoing discord between the Korean Intellectual Property Office and Hanmi Pharm over the CJ Corporation's trademark Simvasta (simvastatin), a lipid lowering agent, has intensified in the wake of the KIPO's recent ...
Penile rigidity as primary criteria in choice of impotence drug.
Impotence patients assessed the penile rigidity as the primary criteria in choice of an impotence drug according to a market survey conducted by Sinobate market research company assigned by Bayer-GSK.
The survey wa...
Hanmi's new amlodipine salt to get patent approval first in Korea.
The patent for amlodpine camsylate, a new salt of amlodpine and anti-hypertension drug, (brand name: Amodipine) has been approved for the first time in Korea under the patent registration No. 0452491.
Amlodpine ca...
Nifidipine may be most effective intervention for stable angina
Data presented at the October 16 Asia-Pacific symposium in Seoul showed that Bayer's Adalat (nifedipine) reduces the risk of coronary artery disease, explained Professor George Nole from the University of Zurich, depa...
Successful licensing needs smooth communication
To be successful in the global licensing front depends on the smooth communication between both firms, problem-solving networks and executives' strong determination and sustained follow-up endeavor after contract, sai...
